Researchers have discovered how a particular protein affects the growth and spread of colon cancer in humans. The study not ...

A reduced number of master signalling pathways operate during development, acting repeatedly at different moments and regions in the embryo and eliciting diverse cellular responses. This raises the ...

Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX® ) and mFOLFOX6 ...